Do we still need cryoprecipitate? Cryoprecipitate and fibrinogen concentrate as treatments for major hemorrhage — how do they compare?

References

• Hunt BJ, Allard S, Keeling D, et al. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015;170:788–803.
   PubMed Web of Science ®Google Scholar
• Perry DJ, Todd T. 2013. [Accessed 2017 Dec 27]. Avilable from: http://www.practical-haemostasis.com.
   Google Scholar
• Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360–365.
   PubMed Web of Science ®Google Scholar
• Fullard JF. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des. 2004;10:1567–1576.
   PubMed Web of Science ®Google Scholar
• Narayanan S. Multifunctional roles of thrombin. Ann Clin Lab Sci. 1999;29:275–280.
   PubMed Web of Science ®Google Scholar
• Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.
   PubMed Web of Science ®Google Scholar
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.
   PubMed Web of Science ®Google Scholar
• Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–2116.
   PubMed Web of Science ®Google Scholar
• Khan S, Brohi K, Chana M, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg. 2014;76:561–567;discussion 567–568.
   Web of Science ®Google Scholar
• Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;39:2652–2658.
   PubMed Web of Science ®Google Scholar
• Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11:307–314.
   PubMed Web of Science ®Google Scholar
• Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy. Br J Anaesth. 2014;113:922–934.
   PubMed Web of Science ®Google Scholar
• Tinegate H, Allard S, Grant-Casey J, et al. Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England. Transfus Med. 2012;22:356–361.
   PubMed Web of Science ®Google Scholar
• Anderson MA, Glazebrook B, Cutts B, et al. When do we transfuse cryoprecipitate? Intern Med J. 2013;43:896–902.
   PubMed Web of Science ®Google Scholar
• Alport EC, Callum JL, Nahirniak S, et al. Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines. Transfusion. 2008;48:2122–2127.
   PubMed Web of Science ®Google Scholar
• Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127–1130.
   PubMed Web of Science ®Google Scholar
• CSL Behring UK Limited. Riastap. 2016. [Accessed 2017 Dec 21]. Avilable from: https://www.medicines.org.uk/emc/medicine/24163#
   Google Scholar
• Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10:1342–1351.
   PubMed Web of Science ®Google Scholar
• McQuilten ZK, Wood EM, Bailey M, et al. Fibrinogen is an independent predictor of mortality in major trauma patients: a five-year statewide cohort study. Injury. 2017;48:1074–1081.
   PubMed Web of Science ®Google Scholar
• Nienaber U, Innerhofer P, Westermann I, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury. 2011;42:697–701.
   PubMed Web of Science ®Google Scholar
• Haas T, Fries D, Tanaka KA, et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114:217–224.
   PubMed Web of Science ®Google Scholar
• Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011;71(5 Suppl 1):S427–S434.
   PubMedGoogle Scholar
• Mackie IJ, Kitchen S, Machin SJ, et al. Guidelines on fibrinogen assays. Br J Haematol. 2003;121:396–404.
   PubMed Web of Science ®Google Scholar
• Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2014;54:1389–1405; quiz 1388.
   Google Scholar
• Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270–382.
   PubMed Web of Science ®Google Scholar
• Innerhofer P, Fries D, Mittermayr M, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4:e258–e271.
   PubMed Web of Science ®Google Scholar
• Winearls J, Wullschleger M, Wake E, et al. Fibrinogen early in severe trauma study (FEISTY): study protocol for a randomised controlled trial. Trials. 2017;18:241.
   PubMedGoogle Scholar
• Baksaas-Aasen K, Gall L, Eaglestone S, et al. iTACTIC – implementing treatment algorithms for the correction of trauma-induced coagulopathy: study protocol for a multicentre, randomised controlled trial. Trials. 2017;18:486.
   PubMed Web of Science ®Google Scholar
• Pool JGSA. Production of high potency concentrates of antihemophilic globulin in a closed-bag system. N Engl J Med. 1965;273:1443–1447.
   PubMed Web of Science ®Google Scholar
• Kasper CK. Judith Graham pool and the discovery of cryoprecipitate. Haemophilia. 2012;18:833–835.
   PubMed Web of Science ®Google Scholar
• Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Guidelines for the blood transfusion services in the UK. JPAC, 8th ed. 2013.
   Google Scholar
• Medicines and Healthcare Products Regulatory Agency. Fibryga. 2017. [Accessed 2017 Dec 28]. Avilable from: http://www.mhra.gov.uk/spc-pil/?prodName=FIBRYGA%201G%20POWDER%20FOR%20SOLUTION%20FOR%20INJECTION/INFUSION&subsName=HUMAN%20FIBRINOGEN&pageID=SecondLevel.
   Google Scholar
• LFB Biopharmaceuticals Limited. Fibclot. 2017. [Accessed 2017 Dec 27]. Avilable from: https://www.medicines.org.uk/emc/product/2429.
   Google Scholar
• Costa-Filho R, Hochleitner G, Wendt M, et al. Over 50 years of fibrinogen concentrate. Clin Appl Thromb Hemost. 2016;22:109–114.
   PubMed Web of Science ®Google Scholar
• Stanworth SJ, Davenport R, Curry N, et al. Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice. Br J Surg. 2016;103:357–365.
   PubMed Web of Science ®Google Scholar
• Curry N, Rourke C, Davenport R, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115:76–83.
   PubMed Web of Science ®Google Scholar
• Green L, Backholer L, Wiltshire M, et al. The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours. Transfusion. 2016;56:1356–1361.
   PubMed Web of Science ®Google Scholar
• Soundar EP, Reyes M, Korte L, et al. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours. Blood Transfus. 2017;1–4. [Epub ahead of print]
   PubMedGoogle Scholar
• Nascimento B, Callum J, Tien H, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth. 2016;117:775–782.
   PubMed Web of Science ®Google Scholar
• Godier A, Greinacher A, Faraoni D, et al. Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16:170–174.
   PubMed Web of Science ®Google Scholar
• Johansson PI, Sørensen AM, Perner A, et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15:R272.
   PubMed Web of Science ®Google Scholar
• Sørensen JV. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Blood Coagul Fibrinolysis. 1994;5:43–49.
   PubMed Web of Science ®Google Scholar
• Jensen NH, Stensballe J, Afshari A. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review. Acta Anaesthesiol Scand. 2016;60:1033–1042.
   PubMed Web of Science ®Google Scholar
• Lunde J, Stensballe J, Wikkelsø A, et al. Fibrinogen concentrate for bleeding–a systematic review. Acta Anaesthesiol Scand. 2014;58:1061–1074.
   PubMed Web of Science ®Google Scholar
• Mengoli C, Franchini M, Marano G, et al. The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis. Blood Transfus. 2017;15:318–324.
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs P, Poles D. On behalf of the serious hazards of transfusion (SHOT) steering group: the 2014 annual SHOT report. SHOT, 2014.
   Google Scholar
• Okerberg CK, Williams LA, Kilgore ML, et al. Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation. Vox Sang. 2016;111:292–298.
   PubMed Web of Science ®Google Scholar
• McQuilten ZK, Bailey M, Cameron PA, et al. Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion: a bi-national cohort study. Br J Haematol. 2017;179:131–141.
   PubMed Web of Science ®Google Scholar
• WHO. Maternal mortality. 2016. [Accessed 2017 Dec 30]. Avilable from: http://www.who.int/mediacentre/factsheets/fs348/en/.
   Google Scholar
• Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65:1153–1161.
   PubMedGoogle Scholar
• Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29:125–130.
   PubMed Web of Science ®Google Scholar
• O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17:385–396.
   PubMed Web of Science ®Google Scholar
• Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103:718–727.
   PubMed Web of Science ®Google Scholar
• Armstrong S, Fernando R, Ashpole K, et al. Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. Int J Obstet Anesth. 2011;20:293–298.
   PubMed Web of Science ®Google Scholar
• de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20:135–141.
   PubMed Web of Science ®Google Scholar
• Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015;70(Suppl 1):78–86, e27-e78.
   PubMedGoogle Scholar
• Wikkelsø AJ, Edwards HM, Afshari A, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;114:623–633.
   PubMed Web of Science ®Google Scholar
• Collins PW, Cannings-John R, Bruynseels D, et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth. 2017;119:411–421.
   PubMed Web of Science ®Google Scholar
• Kang Y, Audu P. Coagulation and liver transplantation. Int Anesthesiol Clin. 2006;44:17–36.
   PubMedGoogle Scholar
• Lisman T, Ariëns RA. Alterations in fibrin structure in patients with liver diseases. Semin Thromb Hemost. 2016;42:389–396.
   PubMed Web of Science ®Google Scholar
• Kirchner C, Dirkmann D, Treckmann JW, et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion. 2014;54:2760–2768.
   PubMed Web of Science ®Google Scholar
• Sabate A, Gutierrez R, Beltran J, et al. Impact of preemptive fibrinogen concentrate on transfusion requirements in liver transplantation: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Transplant. 2016;16(8):2421–2429.
   PubMed Web of Science ®Google Scholar